Literature DB >> 5338446

Treatment of lymphosarcoma in the dog with L-asparaginase.

L J Old, E A Boyse, H A Campbell, R S Brodey, J Fidler, J D Teller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5338446     DOI： 10.1002/1097-0142(196707)20:7<1066::aid-cncr2820200709>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

Review 1.  Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.

Authors:  Xavier Thomas; Caroline Le Jeune
Journal:  Int J Hematol Oncol       Date:  2016-05-05

2.  Development of an ELISA to detect circulating anti-asparaginase antibodies in dogs with lymphoid neoplasia treated with Escherichia coli l-asparaginase.

Authors:  J A Kidd; P Ross; A S Buntzman; P R Hess
Journal:  Vet Comp Oncol       Date:  2012-12-18       Impact factor: 2.613

Review 3.  [L-asparaginase and leukemia].

Authors:  E Grundmann
Journal:  Klin Wochenschr       Date:  1969-01-15

4.  [Inhibition of malignant human neoplasms with L-asparaginase].

Authors:  H F Oettgen; H K Schulten
Journal:  Klin Wochenschr       Date:  1969-01-15

5.  Production of L-asparaginase II by Escherichia coli.

Authors:  H Cedar; J H Schwartz
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

Review 6.  [L-asparaginase: A new principle in the chemotherapy of malignant neoplasms].

Authors:  H F Oettgen
Journal:  Blut       Date:  1969-09

7.  A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

Authors:  H B Muss; N Spell; D Scudiery; R L Capizzi; M R Cooper; J Cruz; D V Jackson; F Richards; C L Spurr; D R White
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

8.  Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.

Authors:  Jacob R Cawley; Zachary M Wright; Karri Meleo; Gerald S Post; Craig A Clifford; Kathryn R Vickery; David M Vail; Philip J Bergman; Douglas H Thamm
Journal:  J Vet Intern Med       Date:  2020-02-16       Impact factor: 3.333
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.